Investigation Finds No New Disease in Neurological Cases

A report from Canadian authorities has concluded that there is no evidence of a new disease following numerous reports of neurological symptoms that fueled speculation about a mysterious brain condition.

This investigation, led by New Brunswick’s Chief Medical Officer of Health, aligns with increasing research suggesting that the affected individuals may have recognized illnesses instead.

Neurologist Dr. Alier Marrero identified around 500 individuals in New Brunswick and other provinces with unexplained neurological symptoms.

Officials noted that there was no support for Marrero’s assertion that high levels of herbicides and heavy metals were causing these symptoms. The BBC has reached out to Marrero for his perspective.

Dr. Yves Léger, New Brunswick’s Chief Medical Officer of Health, remarked on Friday, “Regardless of our findings, it remains that there are patients who are quite ill and require support.”

A recent BBC report raised questions about the validity of this cluster of cases, suggesting that many patients might have been misdiagnosed and instead could be dealing with known neurological ailments.

The report also highlighted a distressing situation where at least one patient from the group chose medically assisted dying, listing the unidentified disease as the cause on their death certificate, while another patient was contemplating the same option.

The provincial study, released on Friday, reviewed the cases of 222 patients under Marrero’s care and examined extensive tests he had ordered, which he claimed showed elevated levels of harmful substances.

However, comparisons with broader population data from Atlantic Canada revealed that herbicide levels in these patients were within normal ranges, officials stated.

While a few patients exhibited higher than expected levels of heavy metals, the report noted that it was challenging to verify these findings due to testing irregularities, with no clear evidence linking these levels to neurological health issues.

There were limitations in the review, as some of Marrero’s initial tests were not conducted per the correct guidelines, and many patients had not undergone consistent retesting to see if elevated levels persisted.

Interestingly, nearly 60% of the patients in this group had also seen a second neurologist, and none of those specialists had raised any alarms with health authorities concerning patients’ conditions.

In light of the findings, health officials have stated that any patient referred for unexplained neurological issues will now need assessments from two separate specialists.

Dr. Léger conveyed the growing belief that these patients have identifiable conditions, expressing concern for both their health and care. He mentioned that the details of the investigation would be communicated to Dr. Marrero, emphasizing the need for him to grasp the analysis results.

The information will also be forwarded to the Public Health Agency of Canada for further examination.

Sarah Nesbitt, a patient in the group and an advocate for environmental issues, expressed her worries regarding the study’s limitations but remains hopeful it will lead to better answers and support for those with elevated metal levels.

“Ultimately, it’s about diagnosing the problem and helping patients manage their conditions,” she stated.

This investigation is the second one performed by the province regarding the alleged mystery illness. The previous study, which analyzed the initial 48 patients in the cluster, was published in 2022 and also found no shared exposures, concluding that the patients were likely suffering from various distinct illnesses.

A separate study in the JAMA neurology journal last year echoed the findings of the 2022 report, indicating that the patients had identifiable and known illnesses, including cancer and dementia.

Dr. Anthony Lang, the lead author of the JAMA paper, stated that the current provincial report reinforces the belief that no environmental factor could explain the varied neurological issues observed.

“We did not find a consistent neurological disease among the small group we examined,” he added, underscoring the pain experienced by these patients and their families.

Some patients, including Nesbitt, have pushed back against allegations that Marrero misdiagnosed them, believing he has justifiably raised concerns regarding their elevated metal results.

She shared that some individuals are reluctant to seek another neurologist due to a lack of trust in the healthcare system. “He’s kind, intelligent, and does thorough work,” she noted, praising Marrero for his efforts to provide answers.

Marrero has yet to respond to requests for comments on the report. Last month, he asserted that other senior scientists had previously thought there was a new syndrome in New Brunswick, claiming he was being unfairly portrayed as the sole advocate of this idea.

“They are trying to simplify the narrative,” he said, noting his involvement but not claiming exclusive responsibility. “I stayed involved when others moved on.”